The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies
Open accessAbstract
There is an urgent need for effective countermeasures against the current emergence and accelerating expansion of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Induction of herd immunity by mass vaccination has been a very successful strategy for preventing the spread of many infectious diseases, hence protecting the most vulnerable population groups unable to develop immunity, for example individuals with immunodeficiencies or a weakened immune system due to underlying medical or debilitating conditions. Therefore, vaccination represents one of the most promising counter-pandemic measures to COVID-19. However, to date, no licensed vaccine exists, neither for SARS-CoV-2 nor for the closely related SARS-CoV or Middle East respiratory syndrome-CoV. In addition, a few vaccine candidates have only recently entered human clinical trials, which hampers the progress in tackling COVID-19 infection. Here, we discuss potential prophylactic interventions for SARS-CoV-2 with a focus on the challenges existing for vaccine development, and we review pre-clinical progress and ongoing human clinical trials of COVID-19 vaccine candidates. Although COVID-19 vaccine development is currently accelerated via so-called fast-track programs, vaccines may not be timely available to have an impact on the first wave of the ongoing COVID-19 pandemic. Nevertheless, COVID-19 vaccines will be essential in the future for reducing morbidity and mortality and inducing herd immunity, if SARS-CoV-2 becomes established in the population like for example influenza virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1
van Doremalen, N., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., Tamin, A., Harcourt, J. L., Thornburg, N. J., Gerber, S. I., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2004973 · Cited by 9,951
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Rothan, H. A., & Byrareddy, S. N. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102433 · Cited by 5,840
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
Hui, D. S., I Azhar, E., Madani, T. A., Ntoumi, F., Kock, R., Dar, O., Ippolito, G., Mchugh, T. D., Memish, Z. A., Drosten, C., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.01.009 · Cited by 3,809
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,787
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses
Shereen, M. A., Khan, S., Kazmi, A., Bashir, N., & Siddique, R. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.03.005 · Cited by 3,536
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
Ou, X., Liu, Y., Lei, X., Li, P., Mi, D., Ren, L., Guo, L., Guo, R., Chen, T., Hu, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15562-9 · Cited by 3,097
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C.-C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716153 · Cited by 3,047
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Su, S., Wong, G., Shi, W., Liu, J., Lai, A. C. K., Zhou, J., Liu, W., Bi, Y., & Gao, G. F. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.03.003 · Cited by 2,948
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453
SARS-CoV-2 Infection in Children
Lu, X., Zhang, L., Du, H., Zhang, J., Li, Y. Y., Qu, J., Zhang, W., Wang, Y., Bao, S., Li, Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2005073 · Cited by 2,431
Respiratory virus shedding in exhaled breath and efficacy of face masks
Leung, N. H. L., Chu, D. K. W., Shiu, E. Y. C., Chan, K.-H., McDevitt, J. J., Hau, B. J. P., Yen, H.-L., Li, Y., Ip, D. K. M., Peiris, J. S. M., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0843-2 · Cited by 2,270
Cytokine release syndrome in severe COVID-19
Moore, J. B., & June, C. H. (2020) · Science · doi:10.1126/science.abb8925 · Cited by 1,912
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
Shi, J., Wen, Z., Zhong, G., Yang, H., Wang, C., Huang, B., Liu, R., He, X., Shuai, L., Sun, Z., et al. (2020) · Science · doi:10.1126/science.abb7015 · Cited by 1,911
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Zheng, M., Gao, Y., Wang, G., Song, G., Liu, S., Sun, D., Xu, Y., & Tian, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0402-2 · Cited by 1,768 · cited 2×
“In another study, the function of NK and CD8 T cells was exhausted with the increased expression of natural killer group 2 member A (NKG2A) in COVID19 patients (36).”
BackgroundCoronaviruses post-SARS: update on replication and pathogenesis
Perlman, S., & Netland, J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2147 · Cited by 1,764
Virology, Epidemiology, Pathogenesis, and Control of COVID-19
Jin, Y., Yang, H., Ji, W., Wu, W., Chen, S., Zhang, W., & Duan, G. (2020) · Viruses · doi:10.3390/v12040372 · Cited by 1,603
Prolonged presence of SARS-CoV-2 viral RNA in faecal samples
Wu, Y., Guo, C., Tang, L., Hong, Z., Zhou, J., Dong, X., Yin, H., Xiao, Q., Tang, Y., Qu, X., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30083-2 · Cited by 1,547
COVID-19: towards controlling of a pandemic
Bedford, J., Enria, D., Giesecke, J., Heymann, D. L., Ihekweazu, C., Kobinger, G., Lane, H. C., Memish, Z., Oh, M.-D., Sall, A. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30673-5 · Cited by 1,545
Imai, M., Watanabe, T., Hatta, M., Das, S. C., Ozawa, M., Shinya, K., Zhong, G., Hanson, A., Katsura, H., Watanabe, S., et al. (2012) · Nature · doi:10.1038/nature10831 · Cited by 1,523
Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China
Wang, W., Tang, J., & Wei, F. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25689 · Cited by 1,480
Development of an inactivated vaccine candidate for SARS-CoV-2
Gao, Q., Bao, L., Mao, H., Wang, L., Xu, K., Yang, M., Li, Y., Zhu, L., Wang, N., Lv, Z., et al. (2020) · Science · doi:10.1126/science.abc1932 · Cited by 1,434
Self-citationA Novel Coronavirus Emerging in China — Key Questions for Impact Assessment
Munster, V. J., Koopmans, M., van Doremalen, N., van Riel, D., & de Wit, E. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2000929 · Cited by 1,415
Xu, Y., Li, X., Zhu, B., Liang, H., Fang, C., Gong, Y., Guo, Q., Sun, X., Zhao, D., Shen, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0817-4 · Cited by 1,415
Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak
Zhang, T., Wu, Q., & Zhang, Z. (2020) · Current Biology · doi:10.1016/j.cub.2020.03.022 · Cited by 1,397
BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis
Kaufmann, E., Sanz, J., Dunn, J. L., Khan, N., Mendonça, L. E., Pacis, A., Tzelepis, F., Pernet, E., Dumaine, A., Grenier, J.-C., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.031 · Cited by 1,191
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
Bao, L., Deng, W., Huang, B., Gao, H., Liu, J., Ren, L., Wei, Q., Yu, P., Xu, Y., Qi, F., et al. (2020) · Nature · doi:10.1038/s41586-020-2312-y · Cited by 1,126
Henao-Restrepo, A. M., Camacho, A., Longini, I. M., Watson, C. H., Edmunds, W. J., Egger, M., Carroll, M. W., Dean, N. E., Diatta, I., Doumbia, M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32621-6 · Cited by 1,110
Chan, J. F.-W., Zhang, A. J., Yuan, S., Poon, V. K.-M., Chan, C. C.-S., Lee, A. C.-Y., Chan, W.-M., Fan, Z., Tsoi, H.-W., Wen, L., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa325 · Cited by 1,058
Lethal Infection of K18- hACE2 Mice Infected with Severe Acute Respiratory Syndrome Coronavirus
McCray, P. B., Pewe, L., Wohlford-Lenane, C., Hickey, M., Manzel, L., Shi, L., Netland, J., Jia, H. P., Halabi, C., Sigmund, C. D., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02012-06 · Cited by 1,010
The contribution of vaccination to global health: past, present and future
Greenwood, B. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0433 · Cited by 979
Human Coronavirus: Host-Pathogen Interaction
Fung, T. S., & Liu, D. X. (2019) · Annual Review of Microbiology · doi:10.1146/annurev-micro-020518-115759 · Cited by 960
Zheng, H.-Y., Zhang, M., Yang, C.-X., Zhang, N., Wang, X.-C., Yang, X.-P., Dong, X.-Q., & Zheng, Y.-T. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0401-3 · Cited by 940
Modified mRNA vaccines protect against zika virus infection
Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
Rockx, B., Kuiken, T., Herfst, S., Bestebroer, T., Lamers, M. M., Oude Munnink, B. B., de Meulder, D., van Amerongen, G., van den Brand, J., Okba, N. M. A., et al. (2020) · Science · doi:10.1126/science.abb7314 · Cited by 901
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Jiang, S., Hillyer, C., & Du, L. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.03.007 · Cited by 847
Züst, R., Cervantes-Barragan, L., Habjan, M., Maier, R., Neuman, B. W., Ziebuhr, J., Szretter, K. J., Baker, S. C., Barchet, W., Diamond, M. S., et al. (2011) · Nature Immunology · doi:10.1038/ni.1979 · Cited by 811
Kauffman, K. J., Dorkin, J. R., Yang, J. H., Heartlein, M. W., DeRosa, F., Mir, F. F., Fenton, O. S., & Anderson, D. G. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b02497 · Cited by 796
Kopecky-Bromberg, S. A., Martínez-Sobrido, L., Frieman, M., Baric, R. A., & Palese, P. (2007) · Journal of Virology · doi:10.1128/jvi.01782-06 · Cited by 673
Progress and prospects: immune responses to viral vectors
Nayak, S., & Herzog, R. W. (2010) · Gene Therapy · doi:10.1038/gt.2009.148 · Cited by 634
Lagunas‐Rangel, F. A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25819 · Cited by 606
New Vaccine Technologies to Combat Outbreak Situations
Rauch, S., Jasny, E., Schmidt, K. E., & Petsch, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01963 · Cited by 579
Nikolich-Zugich, J., Knox, K. S., Rios, C. T., Natt, B., Bhattacharya, D., & Fain, M. J. (2020) · GeroScience · doi:10.1007/s11357-020-00186-0 · Cited by 577
Vaccine protection against Zika virus from Brazil
Larocca, R. A., Abbink, P., Peron, J. P. S., de A. Zanotto, P. M., Iampietro, M. J., Badamchi-Zadeh, A., Boyd, M., Ng’ang’a, D., Kirilova, M., Nityanandam, R., et al. (2016) · Nature · doi:10.1038/nature18952 · Cited by 505
Herd immunity – estimating the level required to halt the COVID-19 epidemics in affected countries
Kwok, K. O., Lai, F., Wei, W. I., Wong, S. Y. S., & Tang, J. W. T. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.027 · Cited by 499
T Cell Responses to Whole SARS Coronavirus in Humans
Li, C. K.-F., Wu, H., Yan, H., Ma, S., Wang, L., Zhang, M., Tang, X., Temperton, N. J., Weiss, R. A., Brenchley, J. M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5490 · Cited by 497
Non-specific effects of BCG vaccine on viral infections
Moorlag, S. J. C. F. M., Arts, R. J. W., van Crevel, R., & Netea, M. G. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.04.020 · Cited by 479
Dysregulation of type I interferon responses in COVID-19
Acharya, D., Liu, G., & Gack, M. U. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0346-x · Cited by 454
A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice
Roberts, A., Deming, D., Paddock, C. D., Cheng, A., Yount, B., Vogel, L., Herman, B. D., Sheahan, T., Heise, M., Genrich, G. L., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030005 · Cited by 447
Belzung, C., & Lemoine, M. (2011) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-1-9 · Cited by 438
Antiviral activities of type I interferons to SARS-CoV-2 infection
Mantlo, E., Bukreyeva, N., Maruyama, J., Paessler, S., & Huang, C. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104811 · Cited by 426
H7N9 Influenza Viruses Are Transmissible in Ferrets by Respiratory Droplet
Zhang, Q., Shi, J., Deng, G., Guo, J., Zeng, X., He, X., Kong, H., Gu, C., Li, X., Liu, J., et al. (2013) · Science · doi:10.1126/science.1240532 · Cited by 425
Delany, I., Rappuoli, R., & De Gregorio, E. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201403876 · Cited by 420
Kim, E., Erdos, G., Huang, S., Kenniston, T. W., Balmert, S. C., Carey, C. D., Raj, V. S., Epperly, M. W., Klimstra, W. B., Haagmans, B. L., et al. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102743 · Cited by 404
Long-Term Efficacy of a Hepatitis E Vaccine
Zhang, J., Zhang, X.-F., Huang, S.-J., Wu, T., Hu, Y.-M., Wang, Z.-Z., Wang, H., Jiang, H.-M., Wang, Y.-J., Yan, Q., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1406011 · Cited by 378
Stanley, D. A., Honko, A. N., Asiedu, C., Trefry, J. C., Lau-Kilby, A. W., Johnson, J. C., Hensley, L., Ammendola, V., Abbate, A., Grazioli, F., et al. (2014) · Nature Medicine · doi:10.1038/nm.3702 · Cited by 350
Glass, W. G., Subbarao, K., Murphy, B., & Murphy, P. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4030 · Cited by 340
Jiang, S., Du, L., & Shi, Z. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1723441 · Cited by 330
Milligan, I. D., Gibani, M. M., Sewell, R., Clutterbuck, E. A., Campbell, D., Plested, E., Nuthall, E., Voysey, M., Silva-Reyes, L., McElrath, M. J., et al. (2016) · JAMA · doi:10.1001/jama.2016.4218 · Cited by 324
Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice
Escolano, A., Steichen, J. M., Dosenovic, P., Kulp, D. W., Golijanin, J., Sok, D., Freund, N. T., Gitlin, A. D., Oliveira, T., Araki, T., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.030 · Cited by 320
Systemic delivery of factor IX messenger RNA for protein replacement therapy
Ramaswamy, S., Tonnu, N., Tachikawa, K., Limphong, P., Vega, J. B., Karmali, P. P., Chivukula, P., & Verma, I. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619653114 · Cited by 301
Evaluation of candidate vaccine approaches for MERS-CoV
Wang, L., Shi, W., Joyce, M. G., Modjarrad, K., Zhang, Y., Leung, K., Lees, C. R., Zhou, T., Yassine, H. M., Kanekiyo, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms8712 · Cited by 299
Self-citationProlonged viral shedding in feces of pediatric patients with coronavirus disease 2019
Xing, Y.-H., Ni, W., Wu, Q., Li, W.-J., Li, G.-J., Wang, W.-D., Tong, J.-N., Song, X.-F., Wing-Kin Wong, G., & Xing, Q.-S. (2020) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2020.03.021 · Cited by 298
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
Barouch, D. H., Alter, G., Broge, T., Linde, C., Ackerman, M. E., Brown, E. P., Borducchi, E. N., Smith, K. M., Nkolola, J. P., Liu, J., et al. (2015) · Science · doi:10.1126/science.aab3886 · Cited by 297
Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments
Noyce, R. S., Lederman, S., & Evans, D. H. (2018) · PLOS ONE · doi:10.1371/journal.pone.0188453 · Cited by 294
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
Stadler, C. R., Bähr-Mahmud, H., Celik, L., Hebich, B., Roth, A. S., Roth, R. P., Karikó, K., Türeci, Ö., & Sahin, U. (2017) · Nature Medicine · doi:10.1038/nm.4356 · Cited by 290
SARS-CoV-2: virus dynamics and host response
Chen, Y., & Li, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30235-8 · Cited by 286
Severe Acute Respiratory Syndrome Coronavirus Infection of Golden Syrian Hamsters
Roberts, A., Vogel, L., Guarner, J., Hayes, N., Murphy, B., Zaki, S., & Subbarao, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.503-511.2005 · Cited by 285
Progress and Prospects on Vaccine Development against SARS-CoV-2
Zhang, J., Zeng, H., Gu, J., Li, H., Zheng, L., & Zou, Q. (2020) · Vaccines · doi:10.3390/vaccines8020153 · Cited by 282
Age‐related rhesus macaque models of COVID‐19
Yu, P., Qi, F., Xu, Y., Li, F., Liu, P., Liu, J., Bao, L., Deng, W., Gao, H., Xiang, Z., et al. (2020) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12108 · Cited by 275
Sun, L., Xing, Y., Chen, X., Zheng, Y., Yang, Y., Nichols, D. B., Clementz, M. A., Banach, B. S., Li, K., Baker, S. C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030802 · Cited by 268
An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels
Haagmans, B. L., van den Brand, J. M. A., Raj, V. S., Volz, A., Wohlsein, P., Smits, S. L., Schipper, D., Bestebroer, T. M., Okba, N., Fux, R., et al. (2016) · Science · doi:10.1126/science.aad1283 · Cited by 259
Muthumani, K., Falzarano, D., Reuschel, E. L., Tingey, C., Flingai, S., Villarreal, D. O., Wise, M., Patel, A., Izmirly, A., Aljuaid, A., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac7462 · Cited by 251
Stensballe, L. G., Nante, E., Jensen, I. P., Kofoed, P.-E., Poulsen, A., Jensen, H., Newport, M., Marchant, A., & Aaby, P. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.09.006 · Cited by 247
Ramsauer, K., Schwameis, M., Firbas, C., Müllner, M., Putnak, R. J., Thomas, S. J., Desprès, P., Tauber, E., Jilma, B., & Tangy, F. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70043-5 · Cited by 241
Graham, R. L., Becker, M. M., Eckerle, L. D., Bolles, M., Denison, M. R., & Baric, R. S. (2012) · Nature Medicine · doi:10.1038/nm.2972 · Cited by 230
mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo
Rybakova, Y., Kowalski, P. S., Huang, Y., Gonzalez, J. T., Heartlein, M. W., DeRosa, F., Delcassian, D., & Anderson, D. G. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.05.012 · Cited by 218
A trans-amplifying RNA vaccine strategy for induction of potent protective immunity
Beissert, T., Perkovic, M., Vogel, A., Erbar, S., Walzer, K. C., Hempel, T., Brill, S., Haefner, E., Becker, R., Türeci, Ö., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.09.009 · Cited by 212
Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy
Van Lint, S., Goyvaerts, C., Maenhout, S., Goethals, L., Disy, A., Benteyn, D., Pen, J., Bonehill, A., Heirman, C., Breckpot, K., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2957 · Cited by 210
Blakney, A. K., McKay, P. F., Yus, B. I., Aldon, Y., & Shattock, R. J. (2019) · Gene Therapy · doi:10.1038/s41434-019-0095-2 · Cited by 206
A mouse model for MERS coronavirus-induced acute respiratory distress syndrome
Cockrell, A. S., Yount, B. L., Scobey, T., Jensen, K., Douglas, M., Beall, A., Tang, X.-C., Marasco, W. A., Heise, M. T., & Baric, R. S. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.226 · Cited by 206
Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector Boosting
Yang, Z.-Y., Wyatt, L. S., Kong, W.-P., Moodie, Z., Moss, B., & Nabel, G. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.1.799-803.2003 · Cited by 204
Wilgenhof, S., Van Nuffel, A. M. T., Benteyn, D., Corthals, J., Aerts, C., Heirman, C., Van Riet, I., Bonehill, A., Thielemans, K., & Neyns, B. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt245 · Cited by 203
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Jiang, S., Hillyer, C., & Du, L. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.04.008 · Cited by 199
Roberts, A., Paddock, C., Vogel, L., Butler, E., Zaki, S., & Subbarao, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5833-5838.2005 · Cited by 198
Zhu, F.-C., Wurie, A. H., Hou, L.-H., Liang, Q., Li, Y.-H., Russell, J. B. W., Wu, S.-P., Li, J.-X., Hu, Y.-M., Guo, Q., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32617-4 · Cited by 198
Espeseth, A. S., Cejas, P. J., Citron, M. P., Wang, D., DiStefano, D. J., Callahan, C., Donnell, G. O., Galli, J. D., Swoyer, R., Touch, S., et al. (2020) · npj Vaccines · doi:10.1038/s41541-020-0163-z · Cited by 190
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques
Escolano, A., Gristick, H. B., Abernathy, M. E., Merkenschlager, J., Gautam, R., Oliveira, T. Y., Pai, J., West, A. P., Barnes, C. O., Cohen, A. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1250-z · Cited by 172
Qiao, Y.-L., Wu, T., Li, R.-C., Hu, Y.-M., Wei, L.-H., Li, C.-G., Chen, W., Huang, S.-J., Zhao, F.-H., Li, M.-Q., et al. (2020) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz074 · Cited by 170
Lin, J.-T., Zhang, J.-S., Su, N., Xu, J.-G., Wang, N., Chen, J.-T., Chen, X., Liu, Y.-X., Gao, H., Jia, Y.-P., et al. (2007) · Antiviral Therapy · doi:10.1177/135965350701200702 · Cited by 167
COVID 19: a clue from innate immunity
Birra, D., Benucci, M., Landolfi, L., Merchionda, A., Loi, G., Amato, P., Licata, G., Quartuccio, L., Triggiani, M., & Moscato, P. (2020) · Immunologic Research · doi:10.1007/s12026-020-09137-5 · Cited by 166
Tulman, E. R., Delhon, G. A., Afonso, C. L., Lu, Z., Zsak, L., Sandybayev, N. T., Kerembekova, U. Z., Zaitsev, V. L., Kutish, G. F., & Rock, D. L. (2006) · Journal of Virology · doi:10.1128/jvi.00945-06 · Cited by 165
Alharbi, N. K., Padron-Regalado, E., Thompson, C. P., Kupke, A., Wells, D., Sloan, M. A., Grehan, K., Temperton, N., Lambe, T., Warimwe, G., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.05.032 · Cited by 161
Understanding the T cell immune response in SARS coronavirus infection
Oh, H. J., Gan, S. K., Bertoletti, A., & Tan, Y. (2012) · Emerging Microbes & Infections · doi:10.1038/emi.2012.26 · Cited by 155
Chen, M.-W., Cheng, T.-J. R., Huang, Y., Jan, J., Ma, S.-H., Yu, A. L.-T., Wong, C., & Ho, D. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806901105 · Cited by 154
Mordmüller, B., Sulyok, M., Egger-Adam, D., Resende, M., de Jongh, W. A., Jensen, M. H., Smedegaard, H. H., Ditlev, S. B., Soegaard, M., Poulsen, L., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1140 · Cited by 154
Volz, A., Kupke, A., Song, F., Jany, S., Fux, R., Shams-Eldin, H., Schmidt, J., Becker, C., Eickmann, M., Becker, S., et al. (2015) · Journal of Virology · doi:10.1128/jvi.00614-15 · Cited by 151
Animal models and vaccines for SARS-CoV infection
Roberts, A., Lamirande, E. W., Vogel, L., Jackson, J. P., Paddock, C. D., Guarner, J., Zaki, S. R., Sheahan, T. P., Baric, R. S., & Subbarao, K. (2007) · Virus Research · doi:10.1016/j.virusres.2007.03.025 · Cited by 144
Day, C. W., Baric, R. S., Cai, S. X., Frieman, M. B., Kumaki, Y., Morrey, J. D., Smee, D. F., & Barnard, D. L. (2009) · Virology · doi:10.1016/j.virol.2009.09.023 · Cited by 139
The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Does Not Replicate in Syrian Hamsters
de Wit, E., Prescott, J. B., Baseler, L. J., Bushmaker, T., Thomas, T., Lackemeyer, M. G., Martellaro, C., Milne-Price, S., Haddock, E., Haagmans, B. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069127 · Cited by 139
Pillet, S., Couillard, J., Trépanier, S., Poulin, J., Yassine‐Diab, B., Guy, B., Ward, B. J., & Landry, N. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216533 · Cited by 138
Ouyang, Y., Yin, J., Wang, W., Shi, H., Shi, Y., Xu, B., Qiao, L., Feng, Y., Pang, L., Wei, F., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa462 · Cited by 132
Liebowitz, D. N., Gottlieb, K. A., Kolhatkar, N. S., Garg, S. J., Asher, J., Nazareno, J., Kim, K. H., McIlwain, D. R., & Tucker, S. N. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30584-5 · Cited by 126
Keil, S. D., Bowen, R. A., & Marschner, S. (2016) · Transfusion · doi:10.1111/trf.13860 · Cited by 121
Chen, W., Du, L., Chag, S., Ma, C., Tricoche, N., Tao, X., Seid, C. A., Hudspeth, E. M., Lustigman, S., Tseng, C.-T. K., et al. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.27464 · Cited by 118
Malczyk, A. H., Kupke, A., Prüfer, S., Scheuplein, V., Hutzler, S., Kreuz, D., Beißert, T., Bauer, S., Hubich-Rau, S., Tondera, C., et al. (2015) · Journal of Virology · doi:10.1128/jvi.01815-15 · Cited by 118
Hobson‐Peters, J., Harrison, J. J., Watterson, D., Hazlewood, J. E., Vet, L. J., Newton, N. D., Warrilow, D., Colmant, A. M. G., Taylor, C. T., Huang, B., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax7888 · Cited by 115
The SARS-CoV ferret model in an infection–challenge study
Chu, Y., Ali, G. D., Jia, F., Li, Q., Kelvin, D. J., Couch, R. C., Harrod, K. S., Hutt, J. A., Cameron, C., Weiss, S. R., et al. (2008) · Virology · doi:10.1016/j.virol.2007.12.032 · Cited by 114
Vaccination-induced herd immunity: Successes and challenges
Mallory, M. L., Lindesmith, L. C., & Baric, R. S. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.05.007 · Cited by 113
Development of hybrid viral vectors for gene therapy
Huang, S., & Kamihira, M. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.10.001 · Cited by 111
Moise, L., Gutiérrez, A. H., Kibria, F., Martin, R., Tassone, R., Liu, R., Terry, F. E., Martin, B., & Groot, A. S. D. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1061159 · Cited by 108
Is there an ideal animal model for SARS?
Subbarao, K., & Roberts, A. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.05.007 · Cited by 104
Chen, W., Chag, S., Poongavanam, M., Biter, A. B., Ewere, E. A., de Rezende, W. C., Seid, C. A., Hudspeth, E. M., Pollet, J. B. K., McAtee, C. P., et al. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.04.037 · Cited by 101
Diehl, M. C., Lee, J. C., Daniels, S. E., Tebas, P., Khan, A. S., Giffear, M., Sardesai, N. Y., & Bagarazzi, M. L. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.24702 · Cited by 97
Liu, H., Su, D., Zhang, J., Ge, S., Li, Y., Wang, F., Gravel, M., Roulston, A., Qin, S., Xu, W. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09518-1 · Cited by 97
Landry, N., Pillet, S., Favre, D., Poulin, J., Trépanier, S., Yassine‐Diab, B., & Ward, B. J. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.08.003 · Cited by 95
Will we see protection or reinfection in COVID-19?
Ota, M. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0316-3 · Cited by 93
An Ebola whole-virus vaccine is protective in nonhuman primates
Marzi, A., Halfmann, P., Hill-Batorski, L., Feldmann, F., Shupert, W. L., Neumann, G., Feldmann, H., & Kawaoka, Y. (2015) · Science · doi:10.1126/science.aaa4919 · Cited by 90
Adney, D. R., Wang, L., van Doremalen, N., Shi, W., Zhang, Y., Kong, W., Miller, M. R., Bushmaker, T., Scott, D. P., de Wit, E., et al. (2019) · Viruses · doi:10.3390/v11030212 · Cited by 88
Self-citationGeneration of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines
Wang, P., Zheng, M., Lau, S.-Y., Chen, P., Mok, B. W.-Y., Liu, S., Liu, H., Huang, X., Cremin, C. J., Song, W., et al. (2019) · mBio · doi:10.1128/mbio.02180-19 · Cited by 79
Magnusson, S. E., Reimer, J. M., Karlsson, K. H., Lilja, L., Bengtsson, K. L., & Stertman, L. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.01.039 · Cited by 78
Pandey, A., Singh, N., Vemula, S. V., Couëtil, L. L., Katz, J. M., Donis, R. O., Sambhara, S. R., & Mittal, S. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033428 · Cited by 78
Blakney, A. K., Yilmaz, G., McKay, P. F., Becer, C. R., & Shattock, R. J. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00429 · Cited by 76
Scallan, C. D., Tingley, D. W., Lindbloom, J. D., Toomey, J. S., & Tucker, S. N. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00552-12 · Cited by 70
Sautto, G. A., Kirchenbaum, G. A., Abreu, R. B., Ecker, J. W., Pierce, S. R., Kleanthous, H., & Ross, T. M. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900379 · Cited by 70
Advancements in the development of subunit influenza vaccines
Zhang, N., Zheng, B., Lu, L., Zhou, Y., Jiang, S., & Du, L. (2014) · Microbes and Infection · doi:10.1016/j.micinf.2014.12.006 · Cited by 69
Garlapati, S., Eng, N. F., Kiros, T. G. G., Kindrachuk, J., Mutwiri, G., Hancock, R. E. W., Halperin, S. A., Potter, A. A., Babiuk, L. A., & Gerdts, V. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.009 · Cited by 68
Hjerrild, K. A., Jin, J., Wright, K. E., Brown, R., Marshall, J. M., Labbé, G. M., Silk, S. E., Cherry, C. J., Clemmensen, S. B., Jørgensen, T. R., et al. (2016) · Scientific Reports · doi:10.1038/srep30357 · Cited by 68
Raghunandan, R., Lu, H., Zhou, B., Guebre‐Xabier, M., Massare, M. J., Flyer, D. C., Fries, L. F., Smith, G., & Glenn, G. M. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.09.030 · Cited by 67
Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein
Escriou, N., Callendret, B., Lorin, V., Combredet, C., Marianneau, P., Février, M., & Tangy, F. (2014) · Virology · doi:10.1016/j.virol.2014.01.002 · Cited by 67
Perez, S. A., Kallinteris, N. L., Bisias, S., Tzonis, P., Georgakopoulou, K., Varla-Leftherioti, M., Papamichail, M., Thanos, A., Hofe, E. V., & Baxevanis, C. N. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0085 · Cited by 66
Janitzek, C. M., Peabody, J., Thrane, S., Carlsen, P. H. R., Theander, T. G., Salanti, A., Chackerian, B., Nielsen, M. A., & Sander, A. F. (2019) · Scientific Reports · doi:10.1038/s41598-019-41522-5 · Cited by 62
Carmon, L., Avivi, I. M., Kovjazin, R., Zuckerman, T., Dray, L., Gatt, M. E., Or, R., & Shapira, M. Y. (2014) · British Journal of Haematology · doi:10.1111/bjh.13245 · Cited by 61
Schwarz, T. F., Huang, L., Valencia, A., Panzer, F., Chiu, C., Decreux, A., Poncelet, S. M., Karkada, N., Folschweiller, N., Lin, L., et al. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1625644 · Cited by 61
Dunkle, L. M., Izikson, R., PATRIARCA, P. A., Goldenthal, K. L., Muse, D. D., & Cox, M. M. J. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix478 · Cited by 60
Asahi‐Ozaki, Y., Itamura, S., Ichinohe, T., Strong, P., Tamura, S., Takahashi, H., Sawa, H., Moriyama, M., Tashiro, M., Sata, T., et al. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.07.018 · Cited by 59
Langley, J. M., MacDonald, L. D., Weir, G. M., MacKinnon‐Cameron, D., Ye, L., McNeil, S., Schepens, B., Saelens, X., Stanford, M. M., & Halperin, S. A. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy177 · Cited by 59
Mueller, S., Stauft, C. B., Kalkeri, R., Koidei, F., Kushnir, A. S., Tasker, S. A., & Coleman, J. R. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.02.056 · Cited by 59
Pérez, P., Marín, M. Q., Lázaro-Frías, A., de Oya, N. J., Blázquez, A.-B., Escribano-Romero, E., Sorzano, C. Ó. S., Ortego, J., Sáiz, J., Estéban, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35724-6 · Cited by 58
Hyer, R. N., & Janssen, R. S. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.08.005 · Cited by 58
Kim, S. J., Nguyen, V. G., Park, Y., Park, B., & Chung, H. (2020) · Vaccines · doi:10.3390/vaccines8020220 · Cited by 58
Hasan, Y., Furtado, L. V., Tergas, A. I., Lee, N. K., Brooks, R. A., McCall, A. R., Golden, D. W., Jolly, S., Fleming, G. F., Morrow, M. P., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.02.031 · Cited by 56
Li, K., Li, Z. Y., Wohlford-Lenane, C., Meyerholz, D. K., Channappanavar, R., An, D., Perlman, S. M., McCray, P. B., & He, B. (2020) · mBio · doi:10.1128/mbio.00554-20 · Cited by 55
Wang, B., He, J., Liu, C., & CHANG, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.02.025 · Cited by 52
Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques
Prescott, J. B., Falzarano, D., de Wit, E., Hardcastle, K., Feldmann, F., Haddock, E., Scott, D. P., Feldmann, H., & Munster, V. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00205 · Cited by 52
Domi, A., Feldmann, F., Basu, R., McCurley, N., Shifflett, K., Emanuel, J., Hellerstein, M. S., Guirakhoo, F., Orlandi, C., Flinko, R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-19041-y · Cited by 49
33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
(2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0423-x · Cited by 49
A novel combination adjuvant platform for human and animal vaccines
Garg, R., Babiuk, L. A., den Hurk, S. V. D. L., & Gerdts, V. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.05.067 · Cited by 48
Green, C., Sande, C., Scarselli, E., Capone, S., Vitelli, A., Nicosia, A., Silva-Reyes, L., Thompson, A., de Lara, C. M., Taylor, K., et al. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.02.003 · Cited by 48
Resik, S., Tejeda, A., Mach, O., Sein, C., Molodecky, N. A., Jarrahian, C., Saganic, L., Zehrung, D., Fonseca, M. C., Díaz, M., et al. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.06.071 · Cited by 47
Ichinohe, T., Ainai, A., Ami, Y., Nagata, N., Iwata, N., Kawaguchi, A., Suzaki, Y., Odagiri, T., Tashiro, M., Takahashi, H., et al. (2010) · Journal of Medical Virology · doi:10.1002/jmv.21824 · Cited by 47
33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
Golinelli, G., Dominici, M., Grisendi, G., Spano, C., Rossignoli, F., & Prapa, M. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0422-y · Cited by 47
Vaccines: An achievement of civilization, a human right, our health insurance for the future
Rappuoli, R., Santoni, A., & Mantovani, A. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20182160 · Cited by 46
Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases
Štrbo, N., Garcia-Soto, A. E., Schreiber, T. H., & Podack, E. R. (2013) · Immunologic Research · doi:10.1007/s12026-013-8468-x · Cited by 45
Razazan, A. P., Nicastro, J., Slavcev, R. A., Barati, N., Arab, A., Mosaffa, F., Jaafari, M. R., & Behravan, J. (2019) · Scientific Reports · doi:10.1038/s41598-018-38371-z · Cited by 45
Koriyama, H., Nakagami, H., Nakagami, F., Osako, M. K., Kyutoku, M., Shimamura, M., Kurinami, H., Katsuya, T., Rakugi, H., & Morishita, R. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04534 · Cited by 44
Lázaro-Frías, A., Gómez‐Medina, S., Sánchez-Sampedro, L., Ljungberg, K., Ustav, M., Liljeström, P., Muñoz‐Fontela, C., Estéban, M., & García‐Arriaza, J. (2018) · Journal of Virology · doi:10.1128/jvi.00363-18 · Cited by 44
Vragniau, C., Bufton, J. C., Garzoni, F., Vassal‐Stermann, É., Rabi, F., Terrat, C., Guidetti, M., Josserand, V., Williams, M., Woods, C. J., et al. (2019) · Science Advances · doi:10.1126/sciadv.aaw2853 · Cited by 44
Kovjazin, R., Volovitz, I., Kundel, Y., Rosenbaum, E., Medalia, G., Horn, G., Smorodinsky, N. I., Brenner, B., & Carmon, L. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.04.103 · Cited by 42
Kajikawa, A., Zhang, L., LaVoy, A. S., Bumgardner, S., Klaenhammer, T. R., & Dean, G. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141713 · Cited by 40
Barati, N., Razazan, A. P., Nicastro, J., Slavcev, R. A., Arab, A., Mosaffa, F., Nikpoor, A. R., Badiee, A., Jaafari, M. R., & Behravan, J. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.03.030 · Cited by 35
Hatta, Y., Boltz, D. A., Sarawar, S. R., Kawaoka, Y., Neumann, G., & Bilsel, P. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.06.039 · Cited by 33
Hatta, Y., Boltz, D. A., Sarawar, S. R., Kawaoka, Y., Neumann, G., & Bilsel, P. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.06.053 · Cited by 33
The effect of riboflavin and ultraviolet light on the infectivity of arboviruses
Faddy, H. M., Prow, N. A., Fryk, J. J., Hall, R. A., Keil, S. D., Goodrich, R. P., & Marks, D. C. (2014) · Transfusion · doi:10.1111/trf.12899 · Cited by 32
Aggarwal, C., Cohen, R. B., Morrow, M. P., Kraynyak, K. A., Sylvester, A. J., Cheung, J., Dickerson, K., Schulten, V. M. J., Knoblock, D. M., Gillespie, E. B., et al. (2020) · Vaccines · doi:10.3390/vaccines8010056 · Cited by 32
Rubsamen, R., Herst, C. V., Lloyd, P. M., & Heckerman, D. E. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.05.071 · Cited by 29
Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets
Stauft, C. B., Yang, C., Coleman, J. R., Boltz, D. A., Chin, C., Kushnir, A. S., & Mueller, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223784 · Cited by 29
Aurisicchio, L., Peruzzi, D., Koo, G. C., Wei, W., Monica, N. L., & Ciliberto, G. (2013) · Human Gene Therapy · doi:10.1089/hum.2013.103 · Cited by 23
Gupta, G., Giannino, V., Rishi, N., & Glueck, R. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.07.051 · Cited by 23
Plans, P., Torner, N., Godoy, P., & Jané, M. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.09.015 · Cited by 22
Huang, J.-M., Sali, M., Leckenby, M. W., Radford, D. S., Huynh, H. A., Delogu, G., Cranenburgh, R. M., & Cutting, S. M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.001 · Cited by 22
Cunha‐Neto, E., Rosa, D. S., Harris, P. E., Olson, T., Morrow, A. M., Ciotlos, S., Herst, C. V., & Rubsamen, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00640 · Cited by 22
Plant‐derived protein bodies as delivery vehicles for recombinant proteins into mammalian cells
Schwestka, J., Tschofen, M., Vogt, S., Marcel, S., Grillari, J., Raith, M., Swoboda, I., & Stöger, E. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27273 · Cited by 22
Cui, X., Chang, L., Li, Y., Lv, Q., Wang, F., Lin, Y., Li, W., Meade, J. D., Walden, J. C., & Liang, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-25652-w · Cited by 21
HIV Replication in Humanized IL-3/GM-CSF-Transgenic NOG Mice
Perdomo-Celis, F., Medina-Moreno, S., Davis, H., Bryant, J., & Zapata, J. C. (2019) · Pathogens · doi:10.3390/pathogens8010033 · Cited by 20
Bumgardner, S., Zhang, L., LaVoy, A. S., Andre, B., Frank, C., Kajikawa, A., Klaenhammer, T. R., & Dean, G. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196950 · Cited by 17
Garg, R., Brownlie, R. M., Latimer, L. J. P., Gerdts, V., Potter, A. A., & den Hurk, S. V. D. L. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.07.021 · Cited by 15
Harnessing the power of genomics and immunoinformatics to produce improved vaccines
Moise, L., Cousens, L. P., Fueyo, J., & Groot, A. S. D. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.534454 · Cited by 14
Pollutants drive atopic dermatitis
Bordon, Y. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.141 · Cited by 12
Building better biotherapeutics and vaccines by design: EpiVax, Inc., an immunology company.
Moise, L., Groot, A. D., Marcello, A., et al. (2013) · PubMed · Cited by 6
Cited by
Cascini, F., Pantovic, A., Al-Ajlouni, Y., Failla, G., & Ricciardi, W. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101113 · Cited by 396
Ndwandwe, D., & Wiysonge, C. S. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.07.003 · Cited by 381
Coccia, M. (2022) · Environmental Research · doi:10.1016/j.envres.2021.111678 · Cited by 282
Chang, J.-J., Ji, Y., Li, Y.-H., Pan, H.-F., & Su, P.-Y. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.05.109 · Cited by 275
A systematic literature review to clarify the concept of vaccine hesitancy
Bussink-Voorend, D., Hautvast, J. L. A., Vandeberg, L., Visser, O., & Hulscher, M. E. J. L. (2022) · Nature Human Behaviour · doi:10.1038/s41562-022-01431-6 · Cited by 260
Metadata
- Authors
- Frederiksen, L. S. F., Zhang, Y., Foged, C., & Thakur, A.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-07-21
- Volume
- 11
- Pages
- 1817-1817
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3045281619
- Cited by
- 287
- References
- 190
- FWCI
- 7.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.